Name: Predicase
Price: 199 USD

K-number	K211499
Device name	23andMe PGS Genetic Risk Report for Hereditary Prostate Cancer (HOXB13-Related)
Applicant	23AndMe, Inc.
Product code	QAZ
Device class	Class II
Decision date	Jan 6, 2022
Decision	Substantially Equivalent
Regulation	866.6090

AI Summary

AI extraction for this record is queued and will appear within 24 hours. View full FDA record →

Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?

Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.

Start free trial →

23andMe PGS Genetic Risk Report for Hereditary Prostate Cancer (HOXB13-Related)

Everything you need for a 510(k) submission. Nothing you don't.